$PCOR

O CONNOR KEVIN J sold $489K of PCOR (indirect holdings)

O CONNOR KEVIN J sold 11,538 indirectly-held shares of PROCORE TECHNOLOGIES, INC. (PCOR) at an average of $42.37 ($41.93–$42.99, $0.49M total) across 3 trades over 2026-07-01 to 2026-07-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · O CONNOR KEVIN J
Published Jul 3, 2026, 1:05 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 3, 2026, 1:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PCOR
Neutral
medium confidence
Mentioned
$PCOR
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PCORNeutralLow
01

Why it matters

The disclosed sale provides transparency on insider activity but does not include new operational, financial, or regulatory developments for Procore.

02

Market read

Traders may note insider selling, but the 10b5-1 structure makes this more of a sentiment datapoint than a fundamental signal.

03

What to watch

The sale is indirect and pre-arranged; without additional context (e.g., other insiders’ concurrent trades), it’s hard to infer company-specific negative information.

Relevance 3/10Novelty 4/10Timing: just-filed Form 4 (filed 2026-07-02; trades 2026-07-01 to 2026-07-02)

Background

The filing is an SEC Form 4 insider transaction by a director, executed under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$PCORNeutralMedium confidence
Context

Procore Technologies director Kevin J. O’Connor sold $488,902 of PCOR shares via a 10b5-1 plan across 3 trades at $41.93–$42.99.

Expected impact

Low near-term impact; any reaction is likely limited to insider-sentiment noise rather than a new catalyst.

Evidence & confidence

Form 4 discloses the transaction size, timing, and 10b5-1 pre-arrangement, which typically reduces interpretive weight versus discretionary selling.

Market effects

Minimal; single insider sale does not reset sector expectations.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can coincide with periods of valuation risk or personal liquidity needs—watch for follow-on filings.

Key entities

  • PROCORE TECHNOLOGIES, INC.

    Issuer of the Form 4 insider transaction; ticker PCOR.

  • O CONNOR KEVIN J

    Director who sold shares via an open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PCORMed

Citizens raises Procore stock price target to $77 on customer feedback

Citizens raised its price target for Procore (NYSE:PCOR) to $77 from $71, maintaining a Market Outperform rating. The increase follows customer feedback and due diligence at the company's conference. Procore's stock is down 13% year-to-date but up 8.6% in the past week. Analysts have mixed views, with targets ranging from $55 to $88. Procore's Q3 2026 earnings are due November 3.

$PCORMed

Procore Technologies (PCOR) Gets A Fresh Look On Zacks Upgrade As Undervalued Narrative Holds

Procore Technologies (PCOR) was upgraded to a Zacks Rank #2 rating, highlighting its earnings outlook. The stock has shown mixed performance, with a 24.75% 90-day return but a 13.49% YTD decline. Analysts estimate a fair value of $69.32, suggesting a 12.6% undervaluation. The company's expansion and cross-selling initiatives are noted as growth drivers, but macro headwinds and competition pose risks. PCOR trades at 6.5x sales, a premium to the sector.